Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
32
ANL Quote, Financials, Valuation and Earnings
Last price:
$1.55
Seasonality move
:
-3.96%
Day range:
$1.46 - $1.55
52-week range:
$0.88 - $2.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.24x
Volume:
22.9K
Avg. volume:
24.9K
1-year change:
-33.57%
Market cap:
$57.2M
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingAdlai Nortye Ltd. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Adlai Nortye Ltd. has an estimated upside of 492.11% from its current price of $1.53.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $1.53.
Fair Value
-
According to the consensus of 1 analyst, Adlai Nortye Ltd. has 492.11% upside to fair value with a price target of -- per share.
ANL vs. S&P 500
-
Over the past 5 trading days, Adlai Nortye Ltd. has underperformed the S&P 500 by -8.62% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Adlai Nortye Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Adlai Nortye Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Adlai Nortye Ltd. reported revenues of --.
Earnings Growth
-
Adlai Nortye Ltd. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Adlai Nortye Ltd. reported earnings per share of --.
Enterprise value:
28.2M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.44x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2022-06-30 | 2023-06-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -$1.7M | -- | -$646K | |
| Operating Income | -- | -- | -$60.9M | -$17.5M | -$16.8M | |
| EBITDA | -- | -- | -$90.3M | -$2.9M | -$16.2M | |
| Diluted EPS | -- | -- | -$0.91 | -$0.10 | -$0.64 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | $64.1M | |
| Total Assets | -- | -- | -- | -- | $71.3M | |
| Current Liabilities | -- | -- | -- | -- | $45.4M | |
| Total Liabilities | -- | -- | -- | -- | $45.8M | |
| Total Equity | -- | -- | -- | -- | $25.5M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2022-06-30 | 2023-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -$41.6M | -- | -$8.2M | |
| Cash From Investing | -- | -- | $27.3M | -- | -$49.1K | |
| Cash From Financing | -- | -- | $9.2M | -- | $9.4M | |
| Free Cash Flow | -- | -- | -$42.4M | -$11.8M | -$8.3M | |
ANL
Sector
Market Cap
$57.2M
$28M
Price % of 52-Week High
51.84%
51.03%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.54%
1-Year Price Total Return
-31.53%
-17.48%
Beta (5-Year)
--
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$1.54
200-day SMA
Sell
Level
$1.70
Bollinger Bands (100)
Sell
Level
1.41 - 1.77
Chaikin Money Flow
Sell
Level
-2M
20-day SMA
Buy
Level
$1.38
Relative Strength Index (RSI14)
Buy
Level
54.53
ADX Line
Sell
Level
22.49
Williams %R
Neutral
Level
-21.8091
50-day SMA
Buy
Level
$1.48
MACD (12, 26)
Buy
Level
0.02
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Neutral
Level
300K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-9.3618)
Sell
CA Score
(Annual)
Level (-2.9272)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (6.0696)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Adlai Nortye Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.
Stock Forecast FAQ
In the current month, ANL has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The ANL average analyst price target in the past 3 months is --.
-
Where Will Adlai Nortye Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Adlai Nortye Ltd. share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Adlai Nortye Ltd.?
Analysts are divided on their view about Adlai Nortye Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Adlai Nortye Ltd. is a Sell and believe this share price will drop from its current level to --.
-
What Is Adlai Nortye Ltd.'s Price Target?
The price target for Adlai Nortye Ltd. over the next 1-year time period is forecast to be -- according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is ANL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Adlai Nortye Ltd. is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of ANL?
You can purchase shares of Adlai Nortye Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Adlai Nortye Ltd. shares.
-
What Is The Adlai Nortye Ltd. Share Price Today?
Adlai Nortye Ltd. was last trading at $1.55 per share. This represents the most recent stock quote for Adlai Nortye Ltd.. Yesterday, Adlai Nortye Ltd. closed at $1.53 per share.
-
How To Buy Adlai Nortye Ltd. Stock Online?
In order to purchase Adlai Nortye Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ANL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ANL
Sector
P/E ratio
--
23.89x
PEG ratio
--
-0.01x
P/B ratio
2.24x
1.82x
Price / LTM sales
--
1.60x
Growth Metrics
ANL
Sector
Revenue growth
--
4.62%
Earnings growth
--
10.88%
Revenue (5-year growth)
--
6.5%
Earnings forecast
-$1.31
-$0.21
Profitability
ANL
Sector
Profitability FY 2024
-$1.9M
$3.5M
Return on invested capital
--
-31.77%
Return on assets
--
-27.96%
Return on equity
--
-37.63%
Earnings Date
Last Earnings Date
Feb
25
Next Earnings Date
Dec
25
Estimated Next Earnings Date
Mar
26
Balance Sheet
ANL
Sector
Total cash
$98M
$26.3M
Short term investments
$7K
$25.7M
Total assets
$71.3M
$78M
Long term debt
--
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
